With 0.15 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.23 million shares. During the session, the Insurance – Property & Casualty company that operates in wider Financial sector, reached to the highest price of $38.88 whereas the lowest price it dropped to was $37.9801. The 52-week range on HMN shows that it touched its highest point at $43.26 and its lowest point at $31.81 during that stretch. It currently has a 1-year price target of $44.00. With its current market cap of 1.56 billion, HMN has annualized dividend of $1.36 while the current yield stands at 3.56%. HMN paid its most recent dividend on 1734307200, while the ex-dividend date for that was 1734307200. Beta for the stock currently stands at 0.33.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HMN was up-trending over the past week, with a rise of 4.40%, but this was down by -8.22% over a month. Three-month performance surged to 4.03% while six-month performance rose 9.18%. The stock gained 14.38% in the past year, while it has lost -2.70% so far this year. A look at the trailing 12-month EPS for HMN yields 2.51 with Next year EPS estimates of 3.72. For the next quarter, that number is 1.02. This implies an EPS growth rate of 67.42% for this year and 44.48% for next year. EPS is expected to grow by 12.70% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 20.00%.
Float and Shares Shorts:
At present, 40.73 million HMN shares are outstanding with a float of 40.54 million shares on hand for trading. On 2024-12-31, short shares totaled 0.85 million, which was 208.0 higher than short shares on 1732838400. In addition to Ms. Marita Zuraitis as the firm’s President, CEO & Director, Mr. Donald Martin Carley serves as its Executive VP, General Counsel, Chief Compliance Officer & Corporate Secretary.
Institutional Ownership:
Through their ownership of 1.0359501 of HMN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HMN since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HMN analysts setting a high price target of 46.0 and a low target of 42.0, the average target price over the next 12 months is 44.0. Based on these targets, HMN could surge 20.51% to reach the target high and rise by 10.03% to reach the target low. Reaching the average price target will result in a growth of 15.27% from current levels.
Analysts have provided yearly estimates in a range of $2.61848 being high and $2.52784 being low. For HMN, this leads to a yearly average estimate of $2.5782. Based on analyst estimates, the high estimate for the next quarter is $1.0 and the low estimate is $0.96. The average estimate for the next quarter is thus $0.97.
